Hemolytic disease of the newborn
0 / 11 complete
type II hypersensitivity p. 110
Hemolytic disease of the newborn is a condition that occurs when fetal red blood cells are destroyed by the mother's antibodies that cross the placenta. This can lead to anemia (a shortage of red blood cells), jaundice (yellowing of the skin and eyes), and other fetal problems. Hemolytic disease of the newborn can develop during pregnancy or after the baby is born. The condition is commonly classified as ABO or Rh subtypes.
Copyright © 2023 Elsevier, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
Cookies are used by this site.
USMLE® is a joint program of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). COMLEX-USA® is a registered trademark of The National Board of Osteopathic Medical Examiners, Inc. NCLEX-RN® is a registered trademark of the National Council of State Boards of Nursing, Inc. Test names and other trademarks are the property of the respective trademark holders. None of the trademark holders are endorsed by nor affiliated with Osmosis or this website.